Skip to main content
. 2016 Sep 6;7(43):70353–70363. doi: 10.18632/oncotarget.11857

Table 5. Multivariate analysis of proposed pathologic index 3 and clinical parameters for DFS.

Variable Hazard ratio (95% CI) P-value
Age 0.984 (0.947-1.023) 0.428
Sex 0.855 (0.397-1.841) 0.689
TNM Stage 1.893 (1.403-2.554) *<0.001
Tertile group according to proposed pathologic index 1 1.366 (0.203-9.205) 0.748
Tertile group according to proposed pathologic index 2 0.878 (0.132-5.816) 0.893
Tertile group according to proposed pathologic index 3 3.012 (1.223-7.418) *0.017
Tertile group according to proposed pathologic index 4 0.508 (0.230-1.126) 0.095
*

Statistically significant at P < 0.05.